لا توجد وظائف مفتوحة حاليًا.
Fresenius SE plans to cut 2,000 jobs globally at its generic drugs unit Kabi, or around 5% of the unit's workforce, as part of an efficiency programme, as reported by Handelsblatt.
لا توجد تقييمات بعد.
